889 related articles for article (PubMed ID: 26998764)
1. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease.
Mathewson ND; Jenq R; Mathew AV; Koenigsknecht M; Hanash A; Toubai T; Oravecz-Wilson K; Wu SR; Sun Y; Rossi C; Fujiwara H; Byun J; Shono Y; Lindemans C; Calafiore M; Schmidt TM; Honda K; Young VB; Pennathur S; van den Brink M; Reddy P
Nat Immunol; 2016 May; 17(5):505-513. PubMed ID: 26998764
[TBL] [Abstract][Full Text] [Related]
2. Microbial metabolite sensor GPR43 controls severity of experimental GVHD.
Fujiwara H; Docampo MD; Riwes M; Peltier D; Toubai T; Henig I; Wu SJ; Kim S; Taylor A; Brabbs S; Liu C; Zajac C; Oravecz-Wilson K; Sun Y; Núñez G; Levine JE; van den Brink MRM; Ferrara JLM; Reddy P
Nat Commun; 2018 Sep; 9(1):3674. PubMed ID: 30201970
[TBL] [Abstract][Full Text] [Related]
3. [Microbiome-derived butyrate alleviates intestinal graft versus host reaction].
Bisaccia J; Soudja S
Med Sci (Paris); 2017 Oct; 33(10):862-864. PubMed ID: 28994381
[No Abstract] [Full Text] [Related]
4. Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.
Kawakami K; Minami N; Matsuura M; Iida T; Toyonaga T; Nagaishi K; Arimura Y; Fujimiya M; Uede T; Nakase H
Biochem Biophys Res Commun; 2017 Apr; 485(2):468-475. PubMed ID: 28192120
[TBL] [Abstract][Full Text] [Related]
5. Short chain fatty acids: Postbiotics/metabolites and graft versus host disease colitis.
Riwes M; Reddy P
Semin Hematol; 2020 Jan; 57(1):1-6. PubMed ID: 32690138
[TBL] [Abstract][Full Text] [Related]
6. A single strain of Bacteroides fragilis protects gut integrity and reduces GVHD.
Sofi MH; Wu Y; Ticer T; Schutt S; Bastian D; Choi HJ; Tian L; Mealer C; Liu C; Westwater C; Armeson KE; Alekseyenko AV; Yu XZ
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33554953
[TBL] [Abstract][Full Text] [Related]
7. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
Kumari R; Palaniyandi S; Hildebrandt GC
Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
[TBL] [Abstract][Full Text] [Related]
8. GPR Expression in Intestinal Biopsies From SCT Patients Is Upregulated in GvHD and Is Suppressed by Broad-Spectrum Antibiotics.
Ghimire S; Weber D; Hippe K; Meedt E; Hoepting M; Kattner AS; Hiergeist A; Gessner A; Matos C; Ghimire S; Wolff D; Edinger M; Hoffmann P; Poeck H; Herr W; Holler E
Front Immunol; 2021; 12():753287. PubMed ID: 34777363
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation.
Fujiwara H
Front Immunol; 2021; 12():703298. PubMed ID: 34512627
[TBL] [Abstract][Full Text] [Related]
10. Host NLRP6 exacerbates graft-versus-host disease independent of gut microbial composition.
Toubai T; Fujiwara H; Rossi C; Riwes M; Tamaki H; Zajac C; Liu C; Mathew AV; Byun J; Oravecz-Wilson K; Matsuda I; Sun Y; Peltier D; Wu J; Chen J; Seregin S; Henig I; Kim S; Brabbs S; Pennathur S; Chen G; Reddy P
Nat Microbiol; 2019 May; 4(5):800-812. PubMed ID: 30858572
[TBL] [Abstract][Full Text] [Related]
11. Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease.
Swimm A; Giver CR; DeFilipp Z; Rangaraju S; Sharma A; Ulezko Antonova A; Sonowal R; Capaldo C; Powell D; Qayed M; Kalman D; Waller EK
Blood; 2018 Dec; 132(23):2506-2519. PubMed ID: 30257880
[TBL] [Abstract][Full Text] [Related]
12. Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity.
Yang W; Yu T; Huang X; Bilotta AJ; Xu L; Lu Y; Sun J; Pan F; Zhou J; Zhang W; Yao S; Maynard CL; Singh N; Dann SM; Liu Z; Cong Y
Nat Commun; 2020 Sep; 11(1):4457. PubMed ID: 32901017
[TBL] [Abstract][Full Text] [Related]
13. Acute Graft-versus-Host Disease: Novel Biological Insights.
Teshima T; Reddy P; Zeiser R
Biol Blood Marrow Transplant; 2016 Jan; 22(1):11-6. PubMed ID: 26453971
[TBL] [Abstract][Full Text] [Related]
14. Regulation of humoral immunity by gut microbial products.
Kim M; Kim CH
Gut Microbes; 2017 Jul; 8(4):392-399. PubMed ID: 28332901
[TBL] [Abstract][Full Text] [Related]
15. Intestinal microbiota-related effects on graft-versus-host disease.
Shono Y; Docampo MD; Peled JU; Perobelli SM; Jenq RR
Int J Hematol; 2015 May; 101(5):428-37. PubMed ID: 25812838
[TBL] [Abstract][Full Text] [Related]
16. Donor T-Cell Repertoire Profiling in Recipient Lymphoid and Parenchyma Organs Reveals GVHD Pathogenesis at Clonal Levels After Bone Marrow Transplantation in Mice.
Wu Y; Fu J; Wang H; Yu XZ
Front Immunol; 2021; 12():778996. PubMed ID: 34950143
[TBL] [Abstract][Full Text] [Related]
17. Prolonged Suppression of Butyrate-Producing Bacteria Is Associated With Acute Gastrointestinal Graft-vs-Host Disease and Transplantation-Related Mortality After Allogeneic Stem Cell Transplantation.
Meedt E; Hiergeist A; Gessner A; Dettmer K; Liebisch G; Ghimire S; Poeck H; Edinger M; Wolff D; Herr W; Holler E; Weber D
Clin Infect Dis; 2022 Mar; 74(4):614-621. PubMed ID: 34043764
[TBL] [Abstract][Full Text] [Related]
18. Effect of GVHD on the gut and intestinal microflora.
Ji H; Feng S; Liu Y; Cao Y; Lou H; Li Z
Transpl Immunol; 2024 Feb; 82():101977. PubMed ID: 38184214
[TBL] [Abstract][Full Text] [Related]
19. Global Microbiota-Dependent Histone Acetylation Patterns Are Irreversible and Independent of Short Chain Fatty Acids.
Saiman Y; Shen TD; Lund PJ; Gershuni VM; Jang C; Patel S; Jung S; Furth EE; Friedman ES; Chau L; Garcia BA; Wu GD
Hepatology; 2021 Dec; 74(6):3427-3440. PubMed ID: 34233020
[TBL] [Abstract][Full Text] [Related]
20. Host MyD88 signaling protects against acute graft-versus-host disease after allogeneic bone marrow transplantation.
Xing S; Zhang X; Liu JH; Huang X; Zhou P
Clin Exp Immunol; 2019 Jan; 195(1):121-131. PubMed ID: 30317551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
